Hui Luo

Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial

Yang Cao, Jia Wei, Liang Zou et al. · Journal of Allergy and Clinical Immunology · 2020 · 475 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Integrated analysis of single-cell and bulk RNA sequencing data reveals a pan-cancer stemness signature predicting immunotherapy response

Zhen Zhang, Zixian Wang, Yan‐Xing Chen et al. · Genome Medicine · 2022 · 281 citations · Full text

Medicine, Cancer Biology, Oncology +17

Elevated serum levels of S100A8/A9 and HMGB1 at hospital admission are correlated with inferior clinical outcomes in COVID-19 patients

Liting Chen, Xiaolu Long, Qian Xu et al. · Cellular and Molecular Immunology · 2020 · 275 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Long non-coding RNA XIST regulates gastric cancer progression by acting as a molecular sponge of miR-101 to modulate EZH2 expression

Dongliang Chen, Huai‐Qiang Ju, Yun‐Xin Lu et al. · Journal of Experimental & Clinical Cancer Research · 2016 · 264 citations · Full text

Medicine, Cancer Biology, Oncology +17

Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer

De‐Shen Wang, Hui Luo, Miao‐Zhen Qiu et al. · Medical Oncology · 2012 · 225 citations

Medicine, Immunology, Oncology +10